The world's first mRNA vaccine against a deadly disease

Published Date: 15 Mar 2023

A world first: A research team from Tel Aviv University and the Israel Institute of Biology has developed an anti-mRNA drug that is 100% effective against a single type of virus.

Read Full News

Latest News

HS in Pregnancy Raises Risk for Some Adverse Outcomes

Hidradenitis suppurativa in pregnancy raises risks for hypertensive disorders, cesarean delivery, and preterm birth but not preeclampsia or stillbirth, a meta-analysis finds.

UK Regulator Clears Treatment for PBC-Related Itch

The MHRA has approved linerixibat to treat itch in adults with primary biliary cholangitis, after studies showed it reduced symptoms and improved itch-related sleep disruption.

Abortion Pill Makers Ask US Supreme Court to Restore Mail-order Access

(This May 2 story has been repeated with no changes to the text)

Three Cruise Ship Passengers Die in Suspected Hantavirus Outbreak

Three people have died and three are ill after a Netherlands-based cruise ship was hit by a suspected ⁠outbreak of hantavirus, a rodent-borne virus that can cause fatal...

South Carolina Confirms Second Measles Case in Saluda County

The South Carolina Department of Public Health on Monday confirmed a second measles ⁠case in Saluda County, saying it was linked to the initial case reported on April...

When to Call Neurosurgery for Traumatic Brain Injury

Call neurosurgery for head trauma with falling GCS (especially < 8), new focal deficits or pupillary changes, seizures, or CT showing epidural > 15 mm or subdural > 10 mm.

Todays Updates

Most NMIBC Recurrences Seen in BCG-Exposed Patients

A large real-world study examines outcomes and treatment patterns among patients with non-muscle-invasive bladder cancer treated with BCG.

Todays Updates

Most NMIBC Recurrences Seen in BCG-Exposed Patients

A large real-world study examines outcomes and treatment patterns among patients with non-muscle-invasive bladder cancer treated with BCG.

Latest News

Hidradenitis suppurativa in pregnancy raises risks for hypertensive disorders, cesarean delivery, and preterm birth but not preeclampsia or stillbirth, a meta-analysis finds.

The MHRA has approved linerixibat to treat itch in adults with primary biliary cholangitis, after studies showed it reduced symptoms and improved itch-related sleep disruption.

(This May 2 story has been repeated with no changes to the text)

Three people have died and three are ill after a Netherlands-based cruise ship was hit by a suspected ⁠outbreak of hantavirus, a rodent-borne virus that can cause fatal...

The South Carolina Department of Public Health on Monday confirmed a second measles ⁠case in Saluda County, saying it was linked to the initial case reported on April...

Call neurosurgery for head trauma with falling GCS (especially < 8), new focal deficits or pupillary changes, seizures, or CT showing epidural > 15 mm or subdural > 10 mm.

News All Time

Are Food Allergies Overdiagnosed in Black Patients?

Despite higher levels of specific IgE, Black patients undergo oral food challenge tests far less often than White patients and are more likely to tolerate them, indicating possible overdiagnosis.

MHRA Cuts Nasal Decongestant Spray Limit to 5 Days

The MHRA has cut the recommended use of xylometazoline and oxymetazoline nasal sprays to five days over rebound congestion risks.

Wheat Allergy in Children: Uncommon but Often Outgrown

Wheat allergy in young children is uncommon, but many referred children tolerate wheat protein or have a reaction only to relatively large doses, a new German study shows.

Nerandomilast May Have Mortality Benefit for Autoimmune ILD

‘To have a drug that has an impact on mortality, it’s of huge interest and a benefit for patients with ILD,’ said rheumatologist Voon Ong, MBBS, PhD, who was not involved in the study.

What Drives Norway's Infant Mortality Drop?

Infant mortality continues to fall in Norway as survival improves for extremely premature infants and deaths linked to prematurity, congenital malformations, and sudden infant death syndrome decrease.

Exposure to Molds Tied to Poor Outcomes in Dust Mite Allergy

Exposure to indoor molds is linked to poorer clinical outcomes in patients with house dust mite allergies, a researcher finds.

Fiber-Bacteria Combo May Aid Celiac Disease Recovery

Patients with celiac disease have impaired microbial fiber metabolism and fewer fiber-metabolizing gut microbes. Adding inulin fiber and specific bacteria may speed healing.

Families Need Support Before and After Celiac Diagnoses

Families’ reports of initial emotional distress were mitigated with education and access to resources.

Museum Artworks Offer Lessons in Clinical Vision

Like skin conditions, paintings and sculptures tell a larger story the more closely you look.

Biologic Evidence May Reshape Long-COVID Diagnosis and Care

Researchers have reported biologic abnormalities in long COVID, challenging the view that symptoms are primarily psychosomatic.

Machine Learning Helps Predict Asthma Readmissions in Kids

A machine learning model slightly outperforms a conventional regression model at predicting which children hospitalized for asthma will be readmitted within 180 days.

NICE Recommends First Treatment for Uncontrolled gMG

NICE has recommended rozanolixizumab as the first NHS treatment for adults with uncontrolled generalised myasthenia gravis.

S1 Episode 3: Don't Miss the Zebra: AI in ATTR-CM

ATTR-CM is the zebra hiding among the horses. AI may finally be the tool that finds it. Experts Drs Kevin Alexander and Lily Stern explore what's working, what's not, and what comes next.

This Game Could Make You a Better Doctor: JAMA Study

A nightmare ER shift — and a little anger — led this doctor into a world of decision science, triage heuristics, and building a video game that makes doctors better.

Addressing Food Insecurity in CKD Care

Nutrition and food insecurity among CKD patients can lead to diets of high‑sodium, high‑phosphate convenience foods, yet simple clinic‑level interventions can improve dietary adherence and outcomes.

Intellia's Gene Therapy for Rare Disease cuts Swelling Attacks in Late-stage Trial

Intellia Therapeutics said on Monday its experimental gene-editing therapy reduced the frequency of swelling attacks in ⁠patients with a rare genetic disorder in a...